{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:51:48Z","timestamp":1782370308857,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["825828"],"award-info":[{"award-number":["825828"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["952520"],"award-info":[{"award-number":["952520"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["2020-1.1.6"],"award-info":[{"award-number":["2020-1.1.6"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["2020-1.1.6-JO \u0308 VO \u030b -2021-00013"],"award-info":[{"award-number":["2020-1.1.6-JO \u0308 VO \u030b -2021-00013"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115294","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T17:59:45Z","timestamp":1691603985000},"page":"115294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1\u03b1, IL-1\u03b2, IFN-\u03b3 and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-8343","authenticated-orcid":false,"given":"Tam\u00e1s","family":"Bakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely T.","family":"Kozma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Szebeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-6091","authenticated-orcid":false,"given":"G\u00e1bor","family":"Sz\u00e9n\u00e1si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115294_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cellimm.2011.10.018","article-title":"Induced cytokine response of human PMBC-cultures: correlation of gene expression and secretion profiling and the effect of cryopreservation","volume":"272","author":"Radke","year":"2012","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115294_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesth. Clin."},{"issue":"10","key":"10.1016\/j.biopha.2023.115294_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045027","article-title":"Dynamics of a cytokine storm","volume":"7","author":"Yiu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115294_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4939-7352-1_15","article-title":"Analysis of pro-inflammatory cytokine and type II interferon induction by nanoparticles","volume":"1682","author":"Potter","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"23","key":"10.1016\/j.biopha.2023.115294_bib6","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115294_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2023.115294_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118102","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions","volume":"257","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115294_bib9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262438","article-title":"Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination","volume":"17","author":"Ramatillah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115294_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cytogfr.2020.08.001","article-title":"Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19","volume":"58","author":"Hu","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"18","key":"10.1016\/j.biopha.2023.115294_bib14","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biopha.2023.115294_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/v13122376","article-title":"Systemic inflammation and complement activation parameters predict clinical outcome of severe SARS-CoV-2 infections","volume":"13","author":"Huber","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.biopha.2023.115294_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1413","article-title":"SARS-CoV-2 triggers complement activation through interactions with heparan sulfate","volume":"11","author":"Lo","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.biopha.2023.115294_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714511","article-title":"Lectin pathway mediates complement activation by SARS-CoV-2 proteins","volume":"12","author":"Ali","year":"2021","journal-title":"Front. Immunol."},{"issue":"59","key":"10.1016\/j.biopha.2023.115294_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115294_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11357-021-00495-y","article-title":"A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor","volume":"44","author":"Dezsi","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.biopha.2023.115294_bib20","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2022-0373OC","article-title":"Local complement contributes to pathogenic activation of lung endothelial cells in SARS-CoV-2 infection","author":"Zhang","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2023.115294_bib21","first-page":"187","article-title":"Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro","volume":"632","author":"Ronnelid","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115294_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/JLB.3A0120-114R","article-title":"TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria","volume":"107","author":"Ehrnstrom","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115294_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12185-022-03324-w","article-title":"COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm","volume":"115","author":"Fujimura","year":"2022","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.biopha.2023.115294_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642860","article-title":"Mini-Factor H modulates complement-dependent IL-6 and IL-10 release in an immune cell culture (PBMC) model: potential benefits against cytokine storm","volume":"12","author":"Kozma","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4049\/jimmunol.171.1.417","article-title":"Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A","volume":"171","author":"Sato","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","article-title":"Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nri1745","article-title":"Dectin-1: a signalling non-TLR pattern-recognition receptor","volume":"6","author":"Brown","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115294_bib28","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4049\/jimmunol.178.5.3107","article-title":"Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells","volume":"178","author":"Goodridge","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115294_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12354","article-title":"Autologous serum supplement favours in vitro regenerative paracrine factors synthesis","volume":"50","author":"Haque","year":"2017","journal-title":"Cell Prolif."},{"issue":"9","key":"10.1016\/j.biopha.2023.115294_bib30","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3727\/096368910X550224","article-title":"Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: possible implication for cell transplantation","volume":"20","author":"Ehnert","year":"2011","journal-title":"Cell Transpl."},{"issue":"11","key":"10.1016\/j.biopha.2023.115294_bib31","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.1400341","article-title":"Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice","volume":"192","author":"Huber-Lang","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115294_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2010.05.012","article-title":"Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis","volume":"137","author":"Wang","year":"2010","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115294_bib33","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/eji.201142057","article-title":"Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs","volume":"42","author":"Cheng","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2023.115294_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40560-017-0217-0","article-title":"Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis","volume":"5","author":"Hellerud","year":"2017","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.biopha.2023.115294_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4614-0106-3_9","article-title":"Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis","volume":"946","author":"Bosmann","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2023.115294_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198070","article-title":"COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking","volume":"286","author":"Magro","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.biopha.2023.115294_bib37","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-7-2","article-title":"COVID-19 therapy and vaccination: a clinical narrative review","volume":"12","author":"Chinta","year":"2023","journal-title":"Drugs Context"},{"issue":"2","key":"10.1016\/j.biopha.2023.115294_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14712\/23362936.2023.7","article-title":"Prognostic significance of the coagulation and complement systems in critical COVID-19 infection","volume":"124","author":"Ray","year":"2023","journal-title":"Prague Med. Rep."},{"key":"10.1016\/j.biopha.2023.115294_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2023.03.072","article-title":"Sustained Response to eculizumab in a patient with COVID-19-associated acute thrombotic microangiopathy of the allograft kidney: a case report","author":"Rehman","year":"2023","journal-title":"Transpl. Proc."},{"issue":"12","key":"10.1016\/j.biopha.2023.115294_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115294_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842473","article-title":"Case report: tackling complement hyperactivation with eculizumab in atypical hemolytic uremic syndrome triggered by COVID-19","volume":"13","author":"Leone","year":"2022","journal-title":"Front. Pharm."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:43:49Z","timestamp":1782369829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223010855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S0753332223010855"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115294","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1\u03b1, IL-1\u03b2, IFN-\u03b3 and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115294"}}